Veru
VERU
123 hedge funds and large institutions have $37.6M invested in Veru in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 11 closing their positions.
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
58% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 24
10% more funds holding
Funds holding: 112 → 123 (+11)
6% more call options, than puts
Call options by funds: $549K | Put options by funds: $517K
0.16% less ownership
Funds ownership: 4.11% → 3.95% (-0.16%)
19% less capital invested
Capital invested by funds: $46.2M → $37.6M (-$8.61M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$3.18M |
| 2 |
EAM
Exome Asset Management
New York
|
+$829K |
| 3 |
OC
Oppenheimer & Co
New York
|
+$536K |
| 4 |
AGM
Alpine Global Management
New York
|
+$423K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$306K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.13M |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$2.07M |
| 3 |
Millennium Management
New York
|
-$1.33M |
| 4 |
Morgan Stanley
New York
|
-$1.15M |
| 5 |
PA
Perceptive Advisors
New York
|
-$594K |
VERU Hedge Fund Activity: Q4 2024 in Review
123 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Veru (VERU) for Q4 2024, worth a combined $37.6M — down 19% from $46.2M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new VERU positions and 11 closed out — a net gain of 14 holders — while 38 added to existing stakes and 24 trimmed.
The largest buyer was MPM BioImpact, opening a new position worth an estimated $3.18M. The largest seller was Adage Capital Partners, cutting an estimated $4.13M.
- 123 institutional investors held Veru (VERU) as of Q4 2024, up from 112 in Q3 2024.
- Funds reported $37.6M of Veru stock for Q4 2024, down 19% quarter-over-quarter.
- 25 funds opened new Veru positions in Q4 2024 and 11 closed out, a net change of +14 holders.
- The largest Veru buyer in Q4 2024 was MPM BioImpact, an estimated $3.18M added.
- The largest Veru seller in Q4 2024 was Adage Capital Partners, an estimated $4.13M sold.
Based on aggregated 13F filings for Q4 2024.